Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...
Penumbra’s stock was up about 12% after the deal was announced Thursday morning.
Alameda Post on MSN
Boston Scientific to acquire Alameda-based Penumbra for $14.5 billion
Alameda’s Penumbra, Inc., a medical device company founded by Arani Bose and Adam Elsesser in 2004, has agreed to be acquired ...
Penumbra could generate healthy sales and earnings growth, gaining market share in MT. MT’s share would rise to around 50% in DVT and about 60% in PE. Don’t miss this list of 3 high-yield ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min At Penumbra Inc. Shruthi Narayan ...
Campaign is led by prominent medical societies to minimize discrepancies in treating blood clot conditions, such as in pulmonary embolism, where there are often delays in care (up to 26% of patients ...
Penumbra, Inc. PEN recently announced the FDA’s clearance and the launch of Lightning Flash 2.0, the next generation computer assisted vacuum thrombectomy (CAVT) system to remove venous thrombus and ...
Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results